These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32183416)

  • 21. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
    J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
    Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
    Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol.
    Compton DR; Little PJ; Martin BR; Gilman JW; Saha JK; Jorapur VS; Sard HP; Razdan RK
    J Med Chem; 1990 May; 33(5):1437-43. PubMed ID: 2158563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
    Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
    Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.
    Hayakawa K; Mishima K; Fujiwara M
    Pharmaceuticals (Basel); 2010 Jul; 3(7):2197-2212. PubMed ID: 27713349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol's Upregulation of
    Leishman E; Manchanda M; Thelen R; Miller S; Mackie K; Bradshaw HB
    Cannabis Cannabinoid Res; 2018; 3(1):228-241. PubMed ID: 30515459
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute and subacute bronchial effects of oral cannabinoids.
    Gong H; Tashkin DP; Simmons MS; Calvarese B; Shapiro BJ
    Clin Pharmacol Ther; 1984 Jan; 35(1):26-32. PubMed ID: 6690168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
    Dalterio S; Steger R; Mayfield D; Bartke A
    Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of Cannabinoids in Breast Milk Using QuEChERS and Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry.
    Ramnarine RS; Poklis JL; Wolf CE
    J Anal Toxicol; 2019 Oct; 43(9):746-752. PubMed ID: 31436289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders.
    Kolesarova M; Simko P; Urbanska N; Kiskova T
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
    Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
    Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
    Zuardi AW; Shirakawa I; Finkelfarb E; Karniol IG
    Psychopharmacology (Berl); 1982; 76(3):245-50. PubMed ID: 6285406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ
    Palazzoli F; Citti C; Licata M; Vilella A; Manca L; Zoli M; Vandelli MA; Forni F; Cannazza G
    J Pharm Biomed Anal; 2018 Feb; 150():25-32. PubMed ID: 29202305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
    Chiu P; Olsen DM; Borys HK; Karler R; Turkanis SA
    Epilepsia; 1979 Aug; 20(4):365-75. PubMed ID: 113206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Δ
    Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
    J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol modulation of antinociceptive tolerance to Δ
    Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
    Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
    Turkanis SA; Karler R
    Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.